Under the partnership, Sirona Dx oversees assay design, development and validation, ensuring quality image production.

Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a strategic partnership to deliver a ...

AssureCKD, a Canadian medical device company developing point-of-care solutions for chronic kidney disease (CKD) screening and diagnosis, today announced the appointment of Dr. Aman Khan as Chief ...

Presenting Results of Novel Product for Quality Control of RNA-based Assays MISSISSAUGA, ON / ACCESS Newswire / April 15, 2026 / Microbix Biosystems Inc. (TSX: MBX)(OTCQX:MBXBF, Microbix), a life scie ...

RT-MALS can provide instantaneous measurements of adenovirus particle size and titer during downstream and fill–finish ...

Infectious diseases contribute substantially to morbidity and mortality in both developing and developed regions worldwide. Delays in diagnosis remain a ...

Next-generation biomarker discovery and diagnostics Bio-Techne combines expertise in exosome technologies with experience in the non-invasive liquid biopsy market to create solutions for companion ...

Join Dr. Mikael Kubista, a pioneer of developing and standardizing real-time quantitative PCR (qPCR) and digital PCR (dPCR) assays for research and diagnostics. As a member of the American Association ...

Cell-based assay innovation is reshaping how we discover, validate, and de-risk therapeutic candidates across disease areas. This Research Topic invites ...

The COVID-19 pandemic led to many changes. Among them is universal familiarity with a molecular diagnostic technique that was largely unknown outside clinical use. The polymerase chain reaction — or ...

Proceeds will help enhance workflows and expand single-cell functional assay portfolio * Brad Crutchfield joins as advisor to support early access ...

Positive real-world head-to-head data on GraftAssureTM assay to be presented at the 39th European Immunogenetics and Histocompatibility Conference (EFI2026), April 21--24, 2026 in Edinburgh, Scotland ...